Venetoclax TDM in Newly Diagnosed AML: Exposure-Response and Prognosis
Venetoclax TDM in Newly Diagnosed AML: Exposure-Response and Prognosis
Recruiting · NCT07670130 · Registry updated 2026-08-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Venetoclax TDM in Newly Diagnosed AML: Exposure-Response and Prognosis | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Not stated | 2026-08-06 | NCT07670130 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The First Affiliated Hospital of Soochow University | 164 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The first Affiliated Hospital of Soochow University | Suzhou | China | 1 |